Patient Guide: A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 216 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05455320
Status: ACTIVE_NOT_RECRUITING
Condition: Relapsed or Refractory Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 216 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Little Rock, Arkansas
  • Norwalk, Connecticut
  • • And 213 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily